Sherman Spotlights Advances With RET Inhibitors in Medullary Thyroid Cancer
Season 5, Episode 20, Jul 01, 2021, 06:45 PM
Dr. Sherman discusses the incidence of RET fusions in medullary thyroid cancer and the current clinical landscape of RET inhibitors in the field.